Sub-millimetric, patient-specific brain targeting for functional neurosurgery and real-world outcomes in Parkinson’s Disease and Essential Tremor.

Rebrain at WSSFN 2026

From clinical conviction to clinical evidence. Meet the team in Marseille, September 30 to October 3, and join our Lunch Symposium on Thursday, October 1.

Rebrain will take part in the 2026 World Society for Stereotactic and Functional Neurosurgery Congress (WSSFN), held at the Palais du Pharo in Marseille from September 30 to October 3. You will find the team, in the exhibition foyer next to the main entrance.

Born from academic research and clinical practice, Rebrain is driven by one conviction: improving DBS outcomes also depends on the ability to define a precise, individualized, reliable and reproducible target for each patient. At WSSFN 2026, we will share the next chapter of this journey.

A second expert view on targeting

Visit our stand to discover how Rebrain’s technology supports patient-specific targeting while complementing the neurosurgeon’s expertise. Combining clinical data and supervised metamodels, it provides a second expert view designed to make targeting decisions more precise, individualized and reproducible, for deep brain stimulation as well as lesioning procedures.

Members of the Rebrain team – Emmanuel Cuny, Nejib Zemzemi, David Caumartin, Paolo Dos Santos, Pedro Pelejão, Matt Suminski, Randy Jordan, and Lilou Marchand – will be present throughout the congress to walk you through the approach and discuss your own cases.

Lunch Symposium: “Precision impacting futures”

On Thursday, October 1, Rebrain hosts a scientific Lunch Symposium: Advancing the Next Generation of DBS and Lesioning Through Data-Driven Targeting.

This session gathers international experts in functional neurosurgery to explore how data-driven strategies, supervised metamodels and advanced imaging are shaping the next generation of DBS and lesioning procedures. Professor Emmanuel Cuny will present Rebrain’s latest clinical developments.

A second expert view on targeting

Speakers
Emmanuel Cuny, M.D., Ph.D., Bordeaux University Hospital, France / Rebrain
Jordi Rumià Arboix, M.D., Ph.D., Hospital Clínic de Barcelona, Spain
Shayan Moosa, M.D., University of Virginia, USA
Nejib Zemzemi, Ph.D., Inria / Rebrain

Coordinator
Rees Cosgrove, M.D., FRCSC, FAANS

Thursday, October 1, 12:50 to 14:20, Room 76, Palais du Pharo.
Registration is open to all congress attendees / Seats are limited to 70.

Finding us

Rebrain is located in the exhibition foyer, on the right-hand side after the registration area, next to the coffee area. The Lunch Symposium takes place in Room 76: follow the congress signage from the main entrance.

Find us within WSSFN 26 (Floor plan – How to get to us)

WSSFN 2026 congress (official website)

Palais du Pharo, Marseille, France (Google Map)

See you in Marseille!

Our latest public updates

Rebrain x Worldwide Dystonia Research Center

Rebrain x Worldwide Dystonia Research Center

Partnership aims to develop next-generation data-driven models for personalized deep brain stimulation (DBS) targeting, expanding clinical applications from Parkinson’s disease and essential tremor to dystonia and severe pediatric dystonia with global scalability...

RebrAin 2025/2026: Expanding Reach, Driving Innovation

RebrAin 2025/2026: Expanding Reach, Driving Innovation

Transatlantic expansion RebrAIn’s focus for 2026 is expanding our reach to major neurosurgery reference centers in the US and Europe. Today, our top partner centers by volume are Duke University, University of Virginia (UVA), Pamplona and UCLA. These collaborations...